Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

LNA-anti-miR-150 ameliorates FSGS in vivo

Jan. 28, 2020

Sanifit opens enrollment in phase III study of SNF-472 for calciphylaxis

Jan. 14, 2020

Scripps Research Institute presents myosin-2 ATPase activity inhibitors

Jan. 8, 2020

Phase II study begins for URO-902 in overactive bladder

Dec. 24, 2019

Phase I study of Metablok achieves primary endpoints

Dec. 19, 2019

DiaMedica initiates phase II study of DM-199 in chronic kidney disease

Dec. 18, 2019

Alnylam presents topline data from ILLUMINATE-A phase III study of lumasiran

Dec. 18, 2019

FDA removes partial clinical hold for multiple-ascending-dose study of RGLS-4326

Dec. 17, 2019

Aurinia reports data from pivotal study of voclosporin in lupus nephritis

Dec. 5, 2019

New macrophage metalloelastase inhibitors discovered at Foresee Pharmaceuticals

Dec. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...